群发资讯网

返回主页
voriconazole
伏立康唑
常用释义
英式发音
美式发音
基本释义
  • 伏立康唑
例句
  • 1·Objective To optimize the synthesis technology of voriconazole.
    目的优化伏立康唑的合成工艺。
  • 2·Voriconazole is the first-line antifungal agent for prevention of IFI.
    伏立康唑是预防ifi的一线抗真菌制剂。
  • 3·Early diagnosis and treatment of ia with oral voriconazole result in acceptable mortality rates.
    早期诊断和口服伏立康唑治疗IA,患者死亡率在可接受的范围。
  • 4·Objective to discuss the vitro antibacterial activity of Voriconazole and Fluconazole to frequent Candida in clinic.
    目的探讨伏立康唑和氟康唑对临床念珠菌的体外抗菌活性。
  • 5·"Posaconazole may be a useful salvage option for patients who are not candidates for voriconazole treatment," the authors conclude.
    “泊沙康唑对于非伏立康唑治疗适宜患者可能是一个有用的补救治疗手段,”研究人员总结道。
  • 6·The present drug2013drug interaction can be attributed to a strong inhibitory effect on cytochrome P450-3A4 activity by voriconazole.
    究其原因,是因为伏立康唑对细胞色素P450-3A4活性有强大的抑制作用。
  • 7·Objective:To investigate the effects of voriconazole in patients with malignant hematological disorders complicated by invasive fungal infection.
    目的:探讨伏立康唑治疗恶性血液病患者合并侵袭性真菌感染的结果。
  • 8·Conclusions Voriconazole has a stronger antibacterial activity to Candida than Fluconazole, and is worthy of application in clinic for Candida infection.
    结论伏立康唑比氟康唑对念珠菌有更高的抗菌活性,在抗念珠菌感染时具有较好临床应用价值。
  • 9·Major errors with posaconazole and voriconazole were 12 and 0%, respectively, while very major errors were 0 and 22%, respectively, compared to CLSI standards.
    与CLSI标准相比,泊沙康唑和伏立康唑的主要错误分别为12和0%,而非常重大错误分别为0和22%。
  • 10·Based on the strength of the randomized study, the panel recommends voriconazole for primary treatment of these very uncommon manifestations of invasive aspergillosis (B-III).
    在随机研究的力度的基础上,专家组推荐伏立康唑作为这些少见部位侵袭性曲菌病的用药首选。